美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

The Nightview Fund

33.82

-0.5700-1.66%

盤後：33.840.0164+0.05%16:04 EDT

成交量：1,312.00

成交額：4.44萬

市值：2,989.22萬

市盈率：- -

高：33.94

開：33.94

低：33.82

收：34.39

52周最高：38.42

52周最低：22.38

股本：88.38萬

流通股本：88.38萬

量比：1.25

換手率：0.15%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

The Nightview Fund

交易所：

ARCA

成立時間：

2018

員工人數：

- -

公司地址：

10900 Hefner Pointe Drive,Suite 400,Oklahoma City,Oklahoma,United States

官網：

http://www.nightstartx.com

郵編：

73120

電話：

傳真：

405-896-5825

簡介：

Nightstar Therapeutics Plc最初於2013年5月根據英格蘭和威爾士的法律成立，隨後於2014年1月更名為NightstaRx Limited。該公司是一家領先的臨床階段基因治療公司，專註於開發和治療藥物患有罕見的遺傳性視網膜疾病，否則會進入失明。利用他們在眼科，基因治療和藥物開發方面的專業知識，他們正在開發一系列專有產品候選人，旨在大幅度修改或停止目前尚未批準的治療的遺傳性視網膜疾病的進展。他們的任務是維護和通過構建領先的垂直整合視網膜基因治療公司，恢復患者的視力。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NITE/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NITE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NITE\",,,,,undefined,":{"symbol":"NITE","market":"US","secType":"STK","nameCN":"The Nightview Fund","latestPrice":33.8236,"timestamp":1774036800000,"preClose":34.3936,"halted":0,"volume":1312,"hourTrading":{"tag":"盘后","latestPrice":33.84,"preClose":33.8236,"latestTime":"16:04 EDT","volume":1,"amount":33.8236,"timestamp":1774037062187,"change":0.0164,"changeRate":0.000485,"amplitude":0},"delay":0,"changeRate":-0.016572850762932648,"floatShares":883768,"shares":883768,"eps":0,"marketStatus":"休市中","change":-0.57,"latestTime":"03-20 16:00:00 EDT","open":33.94,"high":33.94,"low":33.8236,"amount":44423.3918,"amplitude":0.003384,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":1,"adrRate":1,"listingDate":1506571200000,"exchange":"ARCA","adjPreClose":34.3936,"sharesOutstanding":943768,"nav":34.37,"aum":30373982.93,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.84,"preClose":33.8236,"latestTime":"16:04 EDT","volume":1,"amount":33.8236,"timestamp":1774037062187,"change":0.0164,"changeRate":0.000485,"amplitude":0},"volumeRatio":1.2452545787261047},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NITE\",,,,,undefined,":{"symbol":"NITE","floatShares":883768,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.2452545787261047,"shares":883768,"dividePrice":0,"high":33.94,"amplitude":0.003384,"preClose":34.3936,"low":33.8236,"week52Low":22.38,"pbRate":"--","week52High":38.42,"institutionHeld":0,"latestPrice":33.8236,"eps":0,"divideRate":0,"volume":1312,"delay":0,"ttmEps":0,"open":33.94,"prevYearClose":36.612,"prevWeekClose":34.2459,"prevMonthClose":35.9065,"prevQuarterClose":36.612,"fiveDayClose":34.2459,"twentyDayClose":35.575,"sixtyDayClose":37.3737},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NITE\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NITE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NITE\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1858671235,"yearFounded":2018,"address":"10900 Hefner Pointe Drive,Suite 400,Oklahoma City,Oklahoma,United States","zipCode":"73120","officePhone":"405-778-8377","officeFax":"405-896-5825"},"stockCompanyDetail":{"websiteUrl":"http://www.nightstartx.com","stockEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":-0.0514},{"period":"3month","weight":-0.0878},{"period":"6month","weight":-0.0443},{"period":"1year","weight":0.273},{"period":"ytd","weight":-0.0762}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Nightstar Therapeutics Plc最初於2013年5月根據英格蘭和威爾士的法律成立，隨後於2014年1月更名為NightstaRx Limited。該公司是一家領先的臨床階段基因治療公司，專註於開發和治療藥物患有罕見的遺傳性視網膜疾病，否則會進入失明。利用他們在眼科，基因治療和藥物開發方面的專業知識，他們正在開發一系列專有產品候選人，旨在大幅度修改或停止目前尚未批準的治療的遺傳性視網膜疾病的進展。他們的任務是維護和通過構建領先的垂直整合視網膜基因治療公司，恢復患者的視力。","exchange":"ARCA","name":"The Nightview Fund","nameEN":"The Nightview Fund"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NITE\",market:\"US\",,,undefined,":null}}